A B S T R A C T Left ventricular function was assessed in six patients with essentially normal cardiopulmonary function, in five patients with primary myocardial disease, and in 16 patients with chronic obstructive pulmonary disease by determining the response of the ventricle to an increased resistance to ejection. Studies were performed at the time of cardiac catheterization and increased resistance to left ventricular ejection was produced by the intravenous infusion of methoxamine.
In the control patients, methoxamine produced an increase in stroke volume index (SVI), in stroke work index (SWI), and stroke power index (SPI), whereas left ventricular end-diastolic pressure (LVEDP) increased only moderately. In contrast SVI, SWI, and SPI fell, whereas LVEDP increased inordinately in the patients with myocardiopathy. The patients with chronic obstructive pulmonary disease responded to the infusion with an increase in SVI, SWI, SPI, and LVEDP comparable to the control patients. Furthermore, in this latter group of patients, a quantitatively similar response was observed in those with essentially normal resting hemodynamics, in those with resting pulmonary hypertension, and in those whose disease had progressed to the stage of right ventricular failure.
This study provides no evidence that chronic obstructive pulmonary disease results in chronic impairment of left ventricular function, but on the contrary, has demonstrated that the left ventricle responds normally to an increased pressure load in these patients.
INTRODUCTION
Impairment of cardiopulmonary hemodynamics is a well recognized complication of chronic obstructive pulmonary disease (COPD). Although the manifestations of the hemodynamic abnormalities usually are related to the development of pulmonary hypertension and right ventricular failure, it has been a clinical impression that. left ventricular dysfunction also may occur as a complication of the lung disease. Indeed, it is stated in a recent textbook of cardiology that the entire heart is affected in cor pulmonale, and not just the right ventricle (1) . Evidence to support this impression has been gained primarily from the observation that patients dying with COPD often have left ventricular hypertrophy at postmortem examination (2) (3) (4) (5) (6) (7) , and the possible mechanisms for this have been summarized (7) . However, the presence of myocardial hypertrophy does not necessarily indicate depressed myocardial function since it has been demonstrated that the hypertrophied myocardium can function normally (8) or even supernormally (9) (10) (11) (12) (13) . Furthermore, definitive conclusions concerning left ventricular function in these patients cannot be made from the vast amount of hemodynamic data accumulated from cardiac catheterization studied which have been summarized recently (14) . None of these studies has been concerned specifically with left ventricular function and the only information pertaining to the function of this ventricle must be inferred from measurements of pulmonary "wedge" pressure at rest and during exercise; this pressure being used as a reflection of left ventricular filling pressure.
Interpretation of these "wedge" pressures, however, is extremely difficult since these patients of-
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Recently Ross and Braunwald reported that the response of the left ventricle in man to an increase in resistance to ejection can be used to characterize the functional state of the ventricle (15) . Employing this technique, the present study was performed to provide more definitive information concerning left ventricular function in patients with chronic obstructive pulmonary disease.
METHODS
27 patients were the subjects of this study. Six patients, ages 40-52 yr (average, 46) served as controls (Group A). Five of the patients had small mediastinal lesions and this study was performed during diagnostic angiography. The remaining patient in this group had "pure" mitral stenosis with a normal resting pulmonary artery pressure and a calculated mitral valve orifice of 2.5 cm2.
Five patients, ages 41-55 yr (average, 46), had primary myocardial disease (Group B). Each of these patients had cardiomegaly, whereas three of the five had a history of congestive heart failure and were receiving a digitalis preparation. None of these patients had congestive heart failure clinically at the time of the study. 16 
RESULTS
The results of the pulmonary function tests in the patients with COPD are given in Table I . 15 patients had a reduced vital capacity, while all 16 patients had a reduced 1-sec vital capacity and maximum voluntary ventilation. In addition, the ratio of residual volume to total lung capacity was increased in each of 14 patients in whom it was determined. Furthermore, an increased total lung capacity, evidence of impaired distribution of inspired air, and a reduced diffusing capacity of carbon monoxide commonly were observed. Oxygen saturation at rest ranged from 60-95 %o and was less than 90%o in 9 of the 16 patients.
Arterial pH was within the normal range in each patient at the time of the study, while arterial pCO2 exceeded 45 mm Hg in only four patients (E. Z., J. C., P. S., and H. L.). Although this group consisted of both those patients with predominant chronic bronchitis and those with predominant pulmonary emphysema, their responses to methoxamine were similar; therefore, they have been grouped together. The hemodynamic data for each individual before and during methoxamine infusion are presented in Tables II, III, and IV. Group A (Table II) Mean systemic arterial pressure increased in each patient from an average of 94 mm Hg at rest to 119 mm Hg during methoxamine infusion. Heart rate, which averaged 83 beats/min during the control period, decreased in each patient to an average of 61 beats/min. Cardiac index (CI) decreased from an average of 3.57 liters/min per m2 at rest to 3.05 liters/min per m2 during drug infusion, decreasing in five or six patients. Resting LVEDP averaged 5 mm Hg and increased to 10 mm Hg, rising in five patients. During the administration of methoxamine, SVI increased in five patients, whereas SWI and SPI increased in all six. SVI averaged 44 ml/m2 at rest and 51 ml/m2 during drug infusion, whereas SWI increased from an average of 65 to 98 g-m/m2, and SPI from a mean of 250 to 303 g-m/sec per M2.
Group B (Table III) Mean systemic arterial pressure averaged 88 mm Hg at rest and increased in each patient to an average of 107 mm Hg with methoxamine. Heart rate decreased from an average of 88 to 81 beats/min, decreasing in each patient. Cardiac index at rest was reduced (< 2.5 liters/min per m,2) in only one patient and averaged 3.18 liters/ min per m2. During methoxamine infusion, CI decreased in each patient to an average of 2.33 liters/min per M2. LVEDP at rest averaged 11 mm Hg and exceeded 12 mm Hg in only two patients. With methoxamine LVEDP rose to abnormal levels in every patient and averaged 21 mm Hg. Concomitantly SVI decreased in all five patients, whereas both SWI and SPI fell in four patients and were unchanged in the remaining one. SVI decreased from a resting average of 37 to 29 mi/M2, SWI from 44 to 39 g-m/m2, and SPI from 180 to 146 g-m/sec per M2.
Group C (Table IV) Mean systemic arterial pressure averaged 88 mm Hg at rest and increased in each patient with methoxamine to an average of 116 mm Hg. Heart rate decreased from a mean of 91 to 80 beats/min, decreasing in 14 patients. CI was less than 2.50 liters/min per M2 at rest in four patients and averaged 2.58 liters/min per M2. However, CI did in five of the six subjects. In contrast, in patients with myocardiopathy, although LVEDP generally increased to an even greater extent, SVI fell in each patient and SWI decreased in four of the five. With one exception, these relationships in all patients with COPD were quite similar to those of the control patients, comparable increases in LVEDP being associated with increases in SWI in each patient and SVI in 15 of the 16 patients.
DISCUSSION
Recently Ross and Braunwald demonstrated that it was possible to characterize the functional state of the left ventricle in man by determining its response to an increased afterload produced by the infusion of angiotensin (15) . They observed that the normal ventricle responded to an increased resistance to ejection with an increase in SWI and SVI, whereas LVEDP increased only moderately. In contrast, although LVEDP increased to an even greater extent, SWI and SVI fell in those patients with abnormal left ventricular function. These observations were supported by previous experiments using isolated hearts (18), intact hearts (19) , and isolated muscle preparations (19, 20) . The results of the present study in which methoxamine was employed to increase afterload in patients with essentially normal cardiac function (Group A) and those with myocardiopathy (Group B), therefore, are in agreement with the results obtained by Ross and Braunwald. It is of interest that such distinctly abnormal responses were observed in each of the patients with myocardiopathy, even though left ventricular function often appeared normal at rest, i.e., CI was normal in four and LVEDP in three of these patients. The infusion of methoxamine into patients with COPD revealed that the left ventricular response in these patients was similar to that of the control patients with no statistically significant differences existing between these two groups in the response of LVEDP, SVI, SWI, or SPI. In contrast, highly significant differences exist between the patients with COPD and those with myocardiopathy in the response of each of these variables.
However, it must be appreciated that the decrease in heart rate during methoxamine infusion was significantly greater in the control patients than in those with COPD. Since differences in the response of heart rate might well produce differences in the response of SVI, and consequently SWI and SPI, comparison of these responses in these two groups must be made with caution. The necessity for making a truly quantitative comparison between these two groups is evident from the observations of Ross and Braunwald. They observed patients, classified as having depressed myocardial function, in whom SVI and SWI increased with increased pressure load but not to an appropriate degree when compared to the increase in LVEDP (15) . Therefore although the patients with COPD clearly do not have left ventricular dysfunction of the severity manifest by Group B, it could not be established conclusively that left ventricular function is normal in the pulmonary disease patients by comparing their response solely with that of the controls. However, when the patients with lung disease were divided into groups on the basis of their impairment of cardiopulmonary hemodynamics at rest and the results compared, strong evidence is provided that left ventricular function is well maintained in this disease.
Regardless of whether these patients with COPD had essentially normal resting hemodynamics or whether they had progressed to the stage of right ventricular failure, essentially identical responses to methoxamine were observed. During the infusion of methoxamine, similar increases in systemic arterial pressure and decreases in heart rate occurred in these three groups of patients (C1, C2, and C3). SVI, SWI, and SPI rose, whereas LVEDP increased moderately in each group with no statistically significant differences observed between these groups in the response of any of these variables. Further statistical analyses comparing the response with methoxamine of each of the group of patients with COPD with that of the control patients revealed that the decrease in heart rate in Group C3 was the only one of the above variables significantly different statistically from those of the Group A patients. In contrast, even in the patients with COPD who had manifest right ventricular failure (Group C3), highly significant differences in the response of SVI, SWI, SPI, and LVEDP and insignificant differences in the changes in heart rate and systemic arterial pressure were observed when compared with those of the patients with myocardiopathy.
It is apparent that the resting cardiac index of the patients with COPD was less than that of the control patients and that this variable decreased progressively as the severity of pulmonary hemodynamics increased. In view of the results of this study, this most likely represents the effect of chronic pulmonary hypertension on right ventricular function. If this were due to left ventricular dysfunction, it would not be expected that SVI, SWI, and SPI would increase with increased afterload, since impairment of left ventricular function, which is not even of the severity to reduce resting CI or elevate LVEDP, still produces such distinctly abnormal responses to increased resistance to ejection (Group B). The effect that the decrease in CI and consequent decrease in SVI might have on the left ventricular response to increased resistance to ejection can be ascertained from previous studies in animals. In experiments in which stroke volume was controlled, it was demonstrated that as the resting stroke volume was increased in the normal ventricle, greater increases in stroke work were produced by similar increases in resistance to ejection (18, 19) . Therefore, the observation that the response of SWI and SPI was no less in Groups C2 and C3, with their lower resting stroke volumes, than in the controls or Group Cl even though a somewhat diminished response might have been expected only strengthens the conclusion that left ventricular function was normal in these patients.
The observation that the resting LVEDP was higher and the resting CI lower in Groups C2 and C3 than the control patients or those in Group C1 might be used as evidence that myocardial function was depressed in the former two groups. However conclusions based on single measurements of LVEDP in patients with obstructive lung disease are potentially erroneous since these values probably do not reflect the true end-diastolic pressure in this chamber. The use of the same fixed point on the thoracic cage as the reference point for zero pressure in patients with normal thoracic cages and in those with increased anteroposterior diameter could lead to apparent differences in intravascular pressure if the geometric relationship of the left ventricular cavity to the reference point were different. Also, it is well known that intrathoracic pressure may be elevated in patients with COPD. This in itself could result in an apparent elevation of LVEDP, although transmural pressure might be normal. Regardless of whether the LVEDP as measured in the patients with COPD represents the true LVEDP, the determination of changes in LVEDP in these patients should be accurate in the absence of changes in ventilation or airway resistance. Respiratory rate was not affected significantly by methoxamine infusion in any of the patients in the present study. Furthermore, minute ventilation was determined in three patients with lung disease and intra-esophageal pressure in three other patients with COPD and no changes were observed during drug administration.
The usefulness of employing changes in LVEDP to assess left ventricular function as performed in this study is dependent upon the ability of this variable to reflect changes in end-diastolic ventricular volume. Although direct measurement of end-diastolic volume would be preferable when possible, considerable evidence has been presented that changes in LVEDP do reflect changes in enddiastolic fiber length (17, 21, 22 acidosis, yet a normal left ventricular response was observed in each of these patients. Also the subsequent course of these patients makes it improbable that the lung disease was not of the severity necessary to produce chronic left ventricular dysfunction. Four of the six patients died of respiratory insufficiency with right ventricular failure within 7-23 months of the time of this study. Postmortem examination revealed marked right ventricular hypertrophy in all, and the left ventricle appeared normal in three. Left ventricular hypertrophy was described in the remaining patient although measurements of wall thickness were not made. This latter finding has been observed in a significant percentage of these patients by several investigators (2-7), although it has not been a universal finding (23) . If left ventricular hypertrophy does occur as a result of COPD, it would appear from the present study that this compensatory mechanism is sufficient to maintain normal left ventricular performance in these patients.
